about
Effect of sympathectomy level on the incidence of compensatory hyperhidrosis after sympathectomy for palmar hyperhidrosis.Photodynamic laser therapy for lesions in the airway.Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer.Early Postoperative Albumin Administration Contributes to Morbidity After the Fontan Operation.The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival.Distribution and likelihood of lymph node metastasis based on the lobar location of nonsmall-cell lung cancer.Maximum standardized uptake values on positron emission tomography of esophageal cancer predicts stage, tumor biology, and survival.Ratio of the maximum standardized uptake value on FDG-PET of the mediastinal (N2) lymph nodes to the primary tumor may be a universal predictor of nodal malignancy in patients with nonsmall-cell lung cancer.Predictors of survival and disease-free survival in patients with resected N1 non-small cell lung cancer.Esophageal trauma.Management of subcutaneous emphysema after pulmonary resection.Rigid bronchoscopy and surgical resection for broncholithiasis and calcified mediastinal lymph nodes.Does minimally invasive thoracic surgery warrant fast tracking of thoracic surgical patients?Changes in pulmonary function tests after neoadjuvant therapy predict postoperative complications.The true false negative rates of esophageal and endobronchial ultrasound in the staging of mediastinal lymph nodes in patients with non-small cell lung cancer.The management of anticoagulants perioperatively.Thoracoscopic and robotic dissection of mediastinal lymph nodes.Technical aspects and early results of robotic esophagectomy with chest anastomosis.Performing robotic lobectomy and segmentectomy: cost, profitability, and outcomes.The incidence and management of postoperative chylothorax after pulmonary resection and thoracic mediastinal lymph node dissection.The efficacy of restaging endobronchial ultrasound in patients with non-small cell lung cancer after preoperative therapy.Left upper lobectomy after coronary artery bypass grafting.Survival and quality of life at least 1 year after pneumonectomy.The benefits of continuous and digital air leak assessment after elective pulmonary resection: a prospective study.Change in maximum standardized uptake value on repeat positron emission tomography after chemoradiotherapy in patients with esophageal cancer identifies complete responders.Outcomes of Patients Who Undergo Cardiac Surgical Procedures After Liver Transplantation.Retention Rate of Electromagnetic Navigation Bronchoscopic Placed Fiducial Markers for Lung Radiosurgery.Health-Related Quality of Life in Adult Survivors After the Fontan Operation.Diagnosis, staging and treatment of patients with non-small cell lung cancer for the surgeon.Comparing robotic lung resection with thoracotomy and video-assisted thoracoscopic surgery cases entered into the Society of Thoracic Surgeons database.The prevalence of nodal upstaging during robotic lung resection in early stage non-small cell lung cancer.General thoracic surgery is safe in patients taking clopidogrel (Plavix).Outcomes of patients with gynecologic malignancies undergoing video-assisted thoracoscopic surgery (VATS) and pleurodesis for malignant pleural effusion.Accessing the aortopulmonary window (#5) and the paraaortic (#6) lymph nodes in patients with non-small cell lung cancer.Intraoperative solumedrol helps prevent postpneumonectomy pulmonary edema.A prospective, double-blinded, randomized trial evaluating the use of preemptive analgesia of the skin before thoracotomy.Optimal technique for the removal of chest tubes after pulmonary resection.The 30- versus 90-day operative mortality after pulmonary resection.Repeat FDG-PET after neoadjuvant therapy is a predictor of pathologic response in patients with non-small cell lung cancer.The safety and efficacy of mediastinoscopy when performed by general thoracic surgeons.
P50
Q33495823-9A7EF96F-AB66-4FCD-BE9B-58808D0FE324Q33584662-D6684DD7-5FF3-4DF5-989E-A7FE94ABDE1EQ34004737-36025CF8-A9B9-403C-88AE-F1CBA1CEC1E4Q36045718-DA418E3B-3813-42CA-88EC-DF979ACCF0D0Q36184383-87C7CF9E-1608-44DC-9E3F-EB3F69AD974FQ36491175-5BE77385-C363-4DAE-9042-4DCA982BEB20Q36545186-673E08D4-22EF-4FEF-850D-4FCF12D5245EQ36802864-518103F2-6D4B-475E-89E8-6059EFD5D2EEQ36858248-73BAD49F-75FE-469C-A518-F41D1152A864Q36890752-B5291EDF-AE6B-4C2A-8A68-1FA2A2F2BB27Q37149560-546315EB-4F7F-401E-AED9-7034D226C994Q37207845-D43005AA-1968-465D-A822-76E9240018AAQ37285098-C3E502F9-BC5B-4F15-826F-5A51DB645C11Q37584711-54A5E4CD-BD77-4C95-BB44-6B695F2DFB9CQ37776331-4377B8E5-044A-462A-8867-6856566C2B55Q37959753-01D57D4D-CA89-487A-B52A-B457F494E503Q38004133-EAA58881-4E9E-4178-AF4B-8B6A42EA7064Q38036487-47E1166D-974E-4A60-A25D-876AC6242043Q38209128-2015ADD1-DAF1-48ED-B7B6-728FE58B4EABQ38210505-4C85F03D-8520-4A35-90DC-3B31F967A11AQ38234723-E1EE1623-B064-4688-8E97-1EA3E0DE23CEQ38543326-BF5DE194-09FC-4D53-B067-C25F7C9EC50BQ39534260-9C302637-A20D-42E6-ADE2-7446F71C7B36Q39854009-99A7C341-D212-4350-863C-23CD57AC68E9Q39997857-317718AC-94FF-46AD-B27F-3DF527193206Q40583554-349287E4-D3FC-477A-B28B-C0538F7A437FQ40675491-67C26CC3-B820-4670-B07D-9E20E2A099D6Q41018302-74E9E979-8E60-42F9-9774-2D3161CCB47CQ41857918-337F2092-93D0-4A30-836F-D9A5D0C5769BQ42644225-1FEB9A44-2F19-4208-B2A7-07E90BE4ADCBQ42654273-7112BDDC-6F41-4EF6-8C47-33183B4C2C6EQ42922012-7AA6B885-57D9-4C3F-B542-9033DDB3291CQ44089597-BCC52EBF-4936-4DA3-8ECA-4111B6413722Q44472895-558AB33D-F30A-42EA-B1D9-947F838083CDQ44608747-0C4683D6-6798-4636-81DB-7637494BE8F1Q44608754-3AB0C766-56C7-4454-8E19-9C5E5A8F56EBQ44727321-7B6D3972-8115-4729-8B3B-357F584C01E2Q45089546-5FD12E6C-72BE-4B25-A98C-A1B31E565240Q45160689-791D5FF3-17E1-4524-B438-8246B784FFC1Q45403473-4064C598-B644-4103-BCEC-D2B3D69D5558
P50
description
researcher ORCID ID = 0000-0002-3704-0319
@en
name
Ayesha S Bryant
@ast
Ayesha S Bryant
@en
Ayesha S Bryant
@es
Ayesha S Bryant
@nl
type
label
Ayesha S Bryant
@ast
Ayesha S Bryant
@en
Ayesha S Bryant
@es
Ayesha S Bryant
@nl
prefLabel
Ayesha S Bryant
@ast
Ayesha S Bryant
@en
Ayesha S Bryant
@es
Ayesha S Bryant
@nl
P1153
7102132050
P31
P496
0000-0002-3704-0319